Transforming growth factor-beta in systemic sclerosis (scleroderma)

Frontiers in Bioscience - Scholar

Volumn 1 S, Issue 1, 2009, Pages 226-235

  Varga, John ^a   Whitfield, Michael L ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Animal models; Dna microarrays; Fibrosis; Gene expression profiling; Review; Scleroderma; Systemic sclerosis; TGF beta

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SYSTEMIC SCLEROSIS;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HUMANS; SCLERODERMA, SYSTEMIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 76649142440     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/e22     Document Type: Article

References (63)

1. Baroni, S. S., Santillo, M., Bevilacqua, F., Luchetti, M., Spadoni, T., Mancini, M., Fraticelli, P., Sambo, P., Funaro, A., Kazlauskas, A., Avvedimento, E. V., Gabrielli, A. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N. Engl. J. Med. 354, 2667-2676 (2006)
2. Duan H, Fleming J, Pritchard DK, Amon LM, Xue J, Arnett HA, Chen G, Breen P, Buckner JH, Molitor JA, Elkon KB, Schwartz SM. Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma. Arthritis Rheum. May; 58(5):1465-74 (2008) (Pubitemid 351705936)
3. Kim D, Peck A, Santer D, Patole P, Schwartz SM, Molitor JA, Arnett FC, Elkon KB. Induction of interferonalpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis. Arthritis Rheum. Jul; 58(7):2163-73 (2008) (Pubitemid 351988110)
4. Fleming JN, Nash RA, McLeod DO, Fiorentino DF, Shulman HM, Connolly MK, Molitor JA, Henstorf G, Lafyatis R, Pritchard DK, Adams LD, Furst DE, Schwartz SM. Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PLoS ONE. Jan 16;3(1):e1452 (2008)
5. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest. Mar; 117(3):557-67 (2007) (Pubitemid 46348510)
6. Trojanowska M. What did we learn by studying scleroderma fibroblasts? Clin Exp Rheumatol. Jan-Feb; 22(3 Suppl 33):S59-63 (2004) (Pubitemid 39162036)
7. Ihn, H. (2007). Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis. J. Dermatol. Sci. (Epub ahead of print). Feb; 49(2):103-13 (2008)
8. Agarwal SK, Tan FK, Arnett FC. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am. Feb; 34(1):17-40 (2008) (Pubitemid 351337628)
9. Arnett, F. C., Cho, M., Chatterjee, S, Aguilar, M. B., Reveille, J. D., and Mayes, M. D. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum. 44, 1359-1362 (2001) (Pubitemid 32537534)
10. Englert, H., Small-McMahon, J., Chambers, P., O'Connor, H., Davis, K., Manolios, N., White, R., Dracos, G., and Brooks, P. Familial risk estimation in systemic sclerosis. Aust. N. Z. J. Med. 29, 36-41 (1999) (Pubitemid 29136655)
11. Feghali-Bostwick, C., Medsger, T. A. Jr., and Wright, T. M. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum. 48, 1956-1963 (2003) (Pubitemid 36828691)
12. Zhou, X., Tan, F. K., Xiong, M., Arnett, F. C., and Feghali-Bostwick, C. A. Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles. Arthritis Rheum. 52, 3305-3314 (2005) (Pubitemid 41447114)
13. Whitfield, M. L., D. R. Finlay, J. I. Murray, O. G. Troyanskaya, J. T. Chi, A. Pergamenschikov, T. H. McCalmont, P. O. Brown, D. Botstein, and M. K. Connolly, Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci U S A, 100(21): p. 12319-24 (2003) (Pubitemid 37271558)
14. Milano, A., S. A. Pendergrass, J. L. Sargent, L. K. George, T. H. McCalmont, M. K. Connolly, and M. L. Whitfield, Molecular Subsets in the Gene Expression Patterns of Scleroderma Skin. PLoS ONE (2008) In press.
15. Gardner, H., J. R. Shearstone, R. Bandaru, T. Crowell, M. Lynes, M. Trojanowska, J. Pannu, E. Smith, S. Jablonska, M. Blaszczyk, F. K. Tan, and M. D. Mayes, Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts. Arthritis Rheum, 54(6): p. 1961-1973 (2006) (Pubitemid 43877946)
16. Tan, F. K., X. Zhou, M. D. Mayes, P. Gourh, X. Guo, C. Marcum, L. Jin, and F. C. Arnett, Jr., Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford), 45(6): p. 694-702 (2006) (Pubitemid 43985337)
17. Duan, H., J. Fleming, D. K. Pritchard, L. M. Amon, J. Xue, H. A. Arnett, G. Chen, P. Breen, J. H. Buckner, J. A. Molitor, K. B. Elkon, and S. M. Schwartz, Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma. Arthritis Rheum, 58(5): p. 1465-74 (2008) (Pubitemid 351705936)
18. Whitfield, M. L., G. Sherlock, A. J. Saldanha, J. I. Murray, C. A. Ball, K. E. Alexander, J. C. Matese, C. M. Perou, M. M. Hurt, P. O. Brown, and D. Botstein, Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell, 13(6): p. 1977-2000 (2002) (Pubitemid 34651487)
19. Chang, H. Y., D. S. Nuyten, J. B. Sneddon, T. Hastie, R. Tibshirani, T. Sorlie, H. Dai, Y. D. He, L. J. van't Veer, H. Bartelink, M. van de Rijn, P. O. Brown, and M. J. van de Vijver, Robustness, scalability, and integration of a woundresponse gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A, 102(10): p. 3738-43 (2005) (Pubitemid 40354681)
20. Chang, H. Y., J. B. Sneddon, A. A. Alizadeh, R. Sood, R. B. West, K. Montgomery, J. T. Chi, M. Rijn Mv, D. Botstein, and P. O. Brown, Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds. PLoS Biol, 2(2): p. E7 (2004)
21. Tan, F. K., B. A. Hildebrand, M. S. Lester, D. N. Stivers, S. Pounds, X. Zhou, D. D. Wallis, D. M. Milewicz, J. D. Reveille, M. D. Mayes, L. Jin, and F. C. Arnett, Jr., Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease. Arthritis Rheum, 52(3): p. 865-76 (2005) (Pubitemid 40365110)
22. Zhou, X., F. K. Tan, M. Xiong, D. M. Milewicz, C. A. Feghali, M. J. Fritzler, J. D. Reveille, and F. C. Arnett, Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts. J. Immunol. 167(12): p. 7126-7133 (2001) (Pubitemid 33144210)
23. Batliwalla, F. M., E. C. Baechler, X. Xiao, W. Li, S. Balasubramanian, H. Khalili, A. Damle, W. A. Ortmann, A. Perrone, A. B. Kantor, P. S. Gulko, M. Kern, R. Furie, T. W. Behrens, and P. K. Gregersen, Peripheral blood gene expression profiling in rheumatoid arthritis. Genes Immun, 6(5): p. 388-97 (2005) (Pubitemid 43090514)
24. Baechler, E. C., F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, P. K. Gregersen, and T. W. Behrens, Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A, 100(5): p. 2610-5 (2003) (Pubitemid 36297546)
25. York, M. R., T. Nagai, A. J. Mangini, R. Lemaire, J. M. van Seventer, Lafyatis R. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists. Arthritis Rheum, 56(3): p. 1010-20 (2007) (Pubitemid 46399451)
26. Greenberg, S. A., J. L. Pinkus, G. S. Pinkus, T. Burleson, D. Sanoudou, R. Tawil, R. J. Barohn, D. S. Saperstein, H. R. Briemberg, M. Ericsson, P. Park, and A. A. Amato, Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol, 57(5): p. 664-78 (2005) (Pubitemid 40628855)
27. Chang, H. Y., J. T. Chi, S. Dudoit, C. Bondre, R. M. van de, D. Botstein, and P. O. Brown, Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A, 99(20): p. 12877-12882 (2002)
28. Ross, D. T., U. Scherf, M. B. Eisen, C. M. Perou, C. Rees, P. Spellman, V. Iyer, S. S. Jeffrey, R. M. van de, M. Waltham, A. Pergamenschikov, J. C. Lee, D. Lashkari, D. Shalon, T. G. Myers, J. N. Weinstein, D. Botstein, and P. O. Brown, Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet, 24(3): p. 227-235 (2000) (Pubitemid 30132189)
29. Palmer, C., M. Diehn, A. A. Alizadeh, and P. O. Brown, Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics, 7: p. 115 (2006)
30. Verrecchia, F., M. L. Chu, and A. Mauviel, Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem, 276(20): p. 17058-62 (2001)
31. Chambers, R. C., P. Leoni, N. Kaminski, G. J. Laurent, and R. A. Heller, Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol, 162(2): p. 533-46 (2003) (Pubitemid 36267860)
32. Zavadil, J., M. Bitzer, D. Liang, Y. C. Yang, A. Massimi, S. Kneitz, E. Piek, and E. P. Bottinger, Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci U S A, 98(12): p. 6686-91 (2001) (Pubitemid 32538277)
33. Renzoni, E. A., D. J. Abraham, S. Howat, X. Shi-Wen, P. Sestini, G. Bou-Gharios, A. U. Wells, S. Veeraraghavan, A. G. Nicholson, C. P. Denton, A. Leask, J. D. Pearson, C. M. Black, K. I. Welsh, and R. M. du Bois, Gene expression profiling reveals novel TGFbeta targets in adult lung fibroblasts. Respir Res, 5(1): p. 24 (2004)
34. Selman, M., T. E. King, and A. Pardo, Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med, 134(2): p. 136-51 (2001) (Pubitemid 32096342)
35. Broekelmann, T. J., A. H. Limper, T. V. Colby, and J. A. McDonald. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A, 88(15): p. 6642-6 (1991) (Pubitemid 21915005)
36. Corrin, B., D. Butcher, B. J. McAnulty, R. M. Dubois, C. M. Black, G. J. Laurent, and N. K. Harrison. Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. Histopathology, 24(2): p. 145-50 (1994) (Pubitemid 24192276)
37. Lakos G, Takagawa S, Varga J. Animal models of scleroderma. Methods Mol Med. 102:377-93 (2004)
38. Lakos G, Melichian D, Wu M, Varga J. Increased bleomycin-induced skin fibrosis in mice lacking the Th1-specific transcription factor T-bet. Pathobiol. 73(5):224-37 (2006) (Pubitemid 46332830)
39. Aliprantis AO, Wang J, Fathman JW, Lemaire R, Dorfman DM, Lafyatis R, Glimcher LH. Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proc Natl Acad Sci U S A. Feb. 20;104(8):2827-30 (2007) Epub 2007 Feb. 16 (Pubitemid 46327964)
40. Takagawa S, Lakos G, Mori Y, Yamamoto T, Nishioka K, Varga J. Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma. J Invest Dermatol. Jul; 121(1):41-50 (2003) (Pubitemid 36900453)
41. Lakos G, Takagawa S, Chen SJ, Ferreira AM, Han G, Masuda K, Wang XJ, DiPietro LA, Varga J. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol. Jul; 165(1):203-17 (2004) (Pubitemid 38821828)
42. Wu M, Varga J. Perspective: animal models of scleroderma. Current Rep Rheum. 2008 (in press)
43. Zhang Y, McCormick LL, Desai SR, Wu C, Gilliam AC. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol. Mar. 15;168(6):3088-98 (2002) (Pubitemid 34211692)
44. Sonnylal, S., Denton, C. P., Zheng, B., Keene, D. R., He, R., Adams, H. P., Vanpelt, C. S., Geng, Y. J., Deng, J. M., Behringer, R. R., and de Crombrugghe, B. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma. Arthritis Rheum. 56, 334-344 (2007) (Pubitemid 46106207)
45. Bonniaud, P., Kolb, M., Galt, T., Robertson, J., Robbins, C., Stampfli, M., Lavery, C., Margetts, P. J., Roberts, A. B., and Gauldie, J. Smad3 null mice develop airspace enlargement and are resistant to TGF-betamediated pulmonary fibrosis. J. Immunol. 173, 2099-2108 (2004) (Pubitemid 38971648)
46. Longo KA, Wright WS, Kang S, Gerin I, Chiang SH, Lucas PC, Opp MR, MacDougald OA. Wnt10b inhibits development of white and brown adipose tissues. J Biol Chem. Aug. 20;279(34):35503-9 (2004) Epub 2004 Jun. 9 (Pubitemid 39100550)
47. Horan GS, Wood S, Ona V, Li DJ, Lukashev ME, Weinreb PH, Simon KJ, Hahm K, Allaire NE, Rinaldi NJ, Goyal J, Feghali-Bostwick CA, Matteson EL, O'Hara C, Lafyatis R, Davis GS, Huang X, Sheppard D, Violette SM. Partial inhibition of integrin alpha (v) beta6 prevents pulmonary fibrosis without exacerbating inflammation. Am J Respir Crit Care Med. Jan 1;177(1):56-65 (2008)
48. Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. Increased expression of integrin alpha (v) beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. J Immunol. Dec. 1;175(11):7708-18 (2005) (Pubitemid 41713471)
49. Varga J, Trojanowska M. Fibrosis in systemic sclerosis. Rheum. Dis. Clinics N. America. 34:1115-145 (2007)
50. Ghosh AK, Varga J. The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis. J Cell Physiol. Dec; 213(3):663-71 (2007) (Pubitemid 350058260)
51. Varga J, Pache B. Anti-transforming growth factor-β therapy for fibrosis: recent progress and implications for systemic sclerosis therapy. Cur Opin Rheumatol (2008) (in press).
52. Daniels, C. E., Wilkes, M. C., Edens, M., Kottom, T. J., Murphy, S. J., Limper, A. H., and Leof, E. B. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J. Clin. Invest. 114, 1308-1316 (2004) (Pubitemid 40385302)
53. Distler, J. H., Jungel, A., Huber, L. C., Schulze-Horsel, U., Zwerina, J., Gay, R. E., Michel, B. A., Hauser, T., Schett, G., Gary, S., and Distler, O. Imatinib mesylate reduces production of extracellular matrix and prevents the development of experimental dermal fibrosis. Arthritis Rheum. 56, 311-322 (2007) (Pubitemid 46106205)
54. Igarashi, A., Nashiro, K., Kikuchi, K., Sato, S., Ihn, H., Grotendorst, G. R., and Takehara, K. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J. Invest. Dermatol. 105, 280-284 (1995)
55. Yasuoka, H., Zhou, Z., Pilewski, J. M., Oury, T. D., Choi, A. M. and Feghali-Bostwick, C. A. Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration. Am. J. Pathol. 169, 1633-1642 (2006) (Pubitemid 351181995)
56. Hsu E, Feghali-Bostwick CA. Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun. N-terminal kinase-and phosphatidylinositol-3 kinase-dependent pathways. Am J Pathol. Jun; 172(6):1580-90 (2008) Epub 2008 May 8. (Pubitemid 351793351)
57. Parel, Y., Aurrand-Lions, M., Scheja, A., Dayer, J. M., Roosnek, E., and Chizzolini, C. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum. 56, 3459-3467 (2007) (Pubitemid 47585442)
58. Wu, M. H., Yokozeki, H., Takagawa, S., Yamamoto, T., Satoh, T., Kaneda, Y., Katayama, I., and Nishioka, K. Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma. Gene Ther. 11, 170-180 (2004) (Pubitemid 38159689)
59. Liu, Y., and Yang, J. Hepatocyte growth factor: new arsenal in the fight against renal fibrosis? Kidney Int. 70, 238-240 (2006) (Pubitemid 44086571)
60. Ghosh, A. K., Bhattacharyya, S., Lakos, G., Chen, S. J., Mori, Y., and Varga, J. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma. Arthritis Rheum. 50, 1305-1318 (2004) (Pubitemid 38480842)
61. Sime PJ. The antifibrogenic potential of PPARgamma ligands in pulmonary fibrosis. J Investig Med. Feb; 56(2):534-8 (2008)
62. Milam JE, Keshamouni VG, Phan SH, Hu B, Gangireddy SR, Hogaboam CM, Standiford TJ, Thannickal VJ, Reddy RC. PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycininduced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. May; 294(5): L891-901 (2008)
63. Wu M, Melichian D, Warner-Blankenship M, Ghosh AK, Chang E, Varga J. Rosiglitazone prevents bleomycininduced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor gamma. In revision, Am J Pathol, (2008)